RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Raia Drogasil S/A Stock

Raia Drogasil S/A Equity 2025

Raia Drogasil S/A Equity

6.43 B BRL

Ticker

RADL3.SA

ISIN

BRRADLACNOR0

In 2025, Raia Drogasil S/A's equity was 6.43 B BRL, a 8.02% increase from the 5.96 B BRL equity in the previous year.

Raia Drogasil S/A Aktienanalyse

What does Raia Drogasil S/A do?

Raia Drogasil SA is a Brazilian company specializing in the sale of pharmaceutical and personal care products. The company is based in São Paulo, Brazil, and operates throughout Latin America. Raia Drogasil was founded in 1905 and is now the largest retail company in Brazil specializing in the sale of drugs and personal care products. Raia Drogasil started as a small family business and over the years, through acquisitions and mergers, became one of the largest retailers in Brazil. The company opened its first pharmacy in São Paulo and expanded its presence throughout the entire territory of Brazil. Today, Raia Drogasil operates approximately 2,200 branches in over 25 states in Brazil. Raia Drogasil's innovative business model is focused on digitalized processes and customer service, ensuring a smooth and user-friendly experience for customers. The company has adapted its business operations in the past due to environmental changes and societal trends. For example, Raia Drogasil has recently strengthened its e-commerce business, allowing customers to conveniently and securely order from home. Raia Drogasil SA operates two different brands: Drogasil and Droga Raia. The Drogasil brand is established more in cities, while the Droga Raia brand is active in smaller towns. Both brand branches offer a wide range of health and beauty products, including drugs, supplements, cosmetics, and baby products. Products offered by Raia Drogasil include general health medications such as pain relievers, vitamins, and cough and cold remedies. Additionally, the company also offers a wide range of products for specific health issues, such as products for diabetics, skincare, and women's well-being. They also carry supplements for various needs, such as immune system support, cardiovascular issues, muscle building, and weight loss. Raia Drogasil also provides a wide selection of cosmetic products for body care and beauty, including skincare and haircare products, makeup, and perfumes. Another special offering is the baby and children's department, where you can find a variety of products for babies and children of all ages, such as baby creams, wipes, and milk powder. In summary, Raia Drogasil SA is one of the leading companies in the pharmacy and personal care industry in Brazil. The company specializes in providing health products to its customers and offers a wide range of products for various needs. This includes medications, supplements, cosmetic products, baby products, and much more. Raia Drogasil has also successfully adapted to ever-changing environmental conditions and societal trends to ensure a smooth and user-friendly experience for its customers. Raia Drogasil S/A ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Raia Drogasil S/A's Equity

Raia Drogasil S/A's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Raia Drogasil S/A's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Raia Drogasil S/A's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Raia Drogasil S/A's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Raia Drogasil S/A’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Raia Drogasil S/A stock

What is the equity of Raia Drogasil S/A this year?

Raia Drogasil S/A has equity of 6.43 B BRL this year.

What was the equity of Raia Drogasil S/A compared to the previous year?

The equity of Raia Drogasil S/A has increased/decreased by 8.02% increased compared to the previous year.

What impact does a high equity have on investors of Raia Drogasil S/A?

A high equity is advantageous for investors of Raia Drogasil S/A as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Raia Drogasil S/A?

A low equity can be a risk for investors of Raia Drogasil S/A, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Raia Drogasil S/A affect the company?

An increase in equity of Raia Drogasil S/A can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Raia Drogasil S/A affect the company?

A reduction in equity of Raia Drogasil S/A can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Raia Drogasil S/A?

Some factors that can affect the equity of Raia Drogasil S/A include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Raia Drogasil S/A so important for investors?

The equity of Raia Drogasil S/A is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Raia Drogasil S/A take to change the equity?

To change equity, Raia Drogasil S/A can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Raia Drogasil S/A pay?

Over the past 12 months, Raia Drogasil S/A paid a dividend of 0.34 BRL . This corresponds to a dividend yield of about 2.43 %. For the coming 12 months, Raia Drogasil S/A is expected to pay a dividend of 0.38 BRL.

What is the dividend yield of Raia Drogasil S/A?

The current dividend yield of Raia Drogasil S/A is 2.43 %.

When does Raia Drogasil S/A pay dividends?

Raia Drogasil S/A pays a quarterly dividend. This is distributed in the months of January, May, May, August.

How secure is the dividend of Raia Drogasil S/A?

Raia Drogasil S/A paid dividends every year for the past 25 years.

What is the dividend of Raia Drogasil S/A?

For the upcoming 12 months, dividends amounting to 0.38 BRL are expected. This corresponds to a dividend yield of 2.7 %.

In which sector is Raia Drogasil S/A located?

Raia Drogasil S/A is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Raia Drogasil S/A kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Raia Drogasil S/A from 1/1/2026 amounting to 0.077 BRL, you needed to have the stock in your portfolio before the ex-date on 7/4/2025.

When did Raia Drogasil S/A pay the last dividend?

The last dividend was paid out on 1/1/2026.

What was the dividend of Raia Drogasil S/A in the year 2024?

In the year 2024, Raia Drogasil S/A distributed 0.308 BRL as dividends.

In which currency does Raia Drogasil S/A pay out the dividend?

The dividends of Raia Drogasil S/A are distributed in BRL.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Raia Drogasil S/A

Our stock analysis for Raia Drogasil S/A Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Raia Drogasil S/A Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.